Butanedioic acid, 2-hydroxy-, compd. with N,N-dimethyl-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-indole-3-ethanamine (1:1)

CAS: 181183-52-8

Rif. AN-AG0022QH

Informazioni sul prodotto

• Nome: Butanedioic acid, 2-hydroxy-, compd. with N,N-dimethyl-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-indole-3-ethanamine (1:1)
• Sinonimi: [u'Almogran', u'almotriptan', u'almotriptan malate', u'Axert', u'Almotriptan malate', u'181183-52-8', u'Almotriptan maleate', u'Almotriptan (malate)', u'LAS 31416 D,L-malate acid', u'PNU 180638E', u'CHEBI:53781', u'PNU-180638E', u'LAS 31416', u'AK110510', u'Almotriptan malate (USAN)', u'Almotriptan malate [USAN]', u'1-(((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedionate (1:1)', u'1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine malate (1:1)', u'1-[[[2-(Dimethyl-amino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine Malate', u'1-(((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedioate (1:1)', u'Butanedioic acid, hydroxy-, compd. with 1-(((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine (1:1)', u'N,N-dimethyl-2-(5-((pyrrolidin-1-ylsulfonyl)methyl)-1H-indol-3-yl)ethan-1-amine 2-hydroxysuccinate', u'N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine; 2-hydroxybutanedioic acid', u'SR-05000001986', u'Axert (TN)', u'Almotriptan Malate See', u'almotriptan-malate-axert', u'AC1L3WYS', u'LAS-31416 Malate', u'Almotriptan malate (Axert)', u'MLS006010048', u'SCHEMBL221131', u'CHEMBL1200521', u'DTXSID1044225', u'C21H31N3O7S', u'LAS-31416 D,L-Malate acid', u'QHATUKWEVNMHRY-UHFFFAOYSA-N', u'Almotriptan Malate(PNU180638)', u'Almotriptan MalateSee: A575201', u'HMS3651A12', u'BCP05632', u'HY-B0383', u'KS-00000FM2', u'MFCD08067740', u'PNU180638', u's2096', u'(zznon-labelled)Almotriptan-d6 Malate', u'AKOS015950790', u'API0000367', u'BCP9000276', u'CS-2455', u'PNU 180638', u'VA10091', u'AN-16757', u'AS-12142', u'SMR004701216', u'AB0011374', u'AB1004826', u'AX8113232', u'LS-181812', u'FT-0661519', u'ST24045938', u'SW219418-1', u'D02825', u'J-011571', u'SR-05000001986-2', u'1-[[3-(2-dimethylaminoethyl)-5-indolyl]methanesulphonyl]pyrrolidine Malate', u'1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine malate', u'3-[2-(Dimethylamino)ethyl]-5-(pyrrolidin-1-ylsulfonylmethyl )-1H-indole malate', u'1-(((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)sulfonyl)pyrrolidine hydroxybutanedioate', u'1-[[[3-(2-dimethylamino)ethyl]-1H-indol-5-yl]-methyl]sulfonyl]pyrrolidine (+/-)-hydroxybutanedioate', u'N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine;2-hydroxybutanedioic acid', u'Almotriptan', u'Axert', u'null', u'UNII-PJP312605E', u'LAS-31416', u'PJP312605E', u'C17H25N3O2S.C4H6O5', u'CID123607', u'CS-O-00817', u'C17-H25-N3-O2-S.C4-H6-O5'], 1-[[3-(2-Dimethylaminoethyl)-5-Indolyl]Methanesulphonyl]Pyrrolidine Malate, 1-[[[2-(Dimethyl-Amino)Ethyl]-1H-Indol-5-Yl]Methyl]Sulfonyl]Pyrrolidine Malate, 2-hydroxybutanedioic acid - N,N-dimethyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine (1:1), Almotrip forte, Almotriptan Malate, Almotriptan Maleate, Almotriptanmaleate, Axert, Butanedioic acid, hydroxy-, compd with 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl]pyrrolidine, Butanedioic acid, hydroxy-, compd. with 1-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]pyrrolidine (1:1), LAS 31416 <span class="text-smallcaps">D</smallcap>,<smallcap>L</span>-malate acid, Las-31416 Malate, N,N-dimethyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine, Pnu 180638, Pnu 180638E, Pyrrolidine, 1-[[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]sulfonyl]-, hydroxybutanedioate (1:1)
• CAS: 181183-52-8
• Marchio: Indagoo

Proprietà chimiche

• Peso molecolare: 469.5517
• Formula: C₂₁H₃₁N₃O₇S
• Purezza: 98%
• Colore/Forma: Solid
• InChI: InChI=1S/C17H25N3O2S.C4H6O5/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20;5-2(4(8)9)1-3(6)7/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3;2,5H,1H2,(H,6,7)(H,8,9)
• InChI key: QHATUKWEVNMHRY-UHFFFAOYSA-N